InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,363.18
(
0.82%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gym gravity

Send PM Follow Ignore
Followers 27
Posts 5261
Boards Moderated 1
Alias Born 08/02/2006

gym gravity

Re: keitern post# 14544

Thursday, 10/30/2008 9:57:42 AM

Thursday, October 30, 2008 9:57:42 AM

Post# of 19309
From RMF:

"4. An ATryn partnership in Japan. Japan has substantial sales of plasma-derived antithrombin, including an approved indication for DIC/sepsis. These plasma-derived sales represent low-hanging fruit for eventual conversion to ATryn. At least one Japanese clinical study will be needed to obtain marketing approval. Dr. Cox has said that a deal is more likely in 2009 than in 2008."


those are off-label plasma derived antithrombin $s in japan?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up